| 3 | Conformational selection guides β-arrestin recruitment at a biased G protein-coupled receptor. (Kleist AB, Jenjak S, Sente A, Laskowski LJ, Szpakowska M, Calkins MM, Anderson EI, McNally LM, Heukers R, Bobkov V, Peterson FC, Thomas MA, Chevigné A, Smit MJ, McCorvy JD, Babu MM, Volkman BF) Science 2022 Jul 08;377(6602):222-228 4 Citations |
| 3 | The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3. (Wedemeyer MJ, Mahn SA, Getschman AE, Crawford KS, Peterson FC, Marchese A, McCorvy JD, Volkman BF) J Biol Chem 2020 Oct 02;295(40):13927-13939 5 Citations |
| 2 | A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration. (Lau S, Feitzinger A, Venkiteswaran G, Wang J, Lewellis SW, Koplinski CA, Peterson FC, Volkman BF, Meier-Schellersheim M, Knaut H) Nat Cell Biol 2020 Mar;22(3):266-273 29 Citations |
| 1 | Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3. (Kleist AB, Peterson F, Tyler RC, Gustavsson M, Handel TM, Volkman BF) Methods Cell Biol 2019;149:259-288 8 Citations |
| 1 | Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. (Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M) PLoS One 2018;13(9):e0204041 4 Citations |
| 1 | Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. (Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M) Open Biol 2018 Jan;8(1) 17 Citations |
| 1 | Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. (Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A) Br J Pharmacol 2018 May;175(9):1419-1438 43 Citations |
| 1 | Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. (Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M) PLoS One 2017;12(11):e0187949 14 Citations |
| 1 | α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. (Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M) J Am Heart Assoc 2017 Aug 17;6(8) 26 Citations |
| 1 | New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. (Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M) Int J Mol Sci 2016 Jun 20;17(5) 28 Citations |
| 1 | Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. (Bach HH 4th, Wong YM, Tripathi A, Nevins AM, Gamelli RL, Volkman BF, Byron KL, Majetschak M) Mol Med 2014 Oct 13;20(1):435-47 29 Citations |
| 3 | CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400 65 Citations |
| 1 | CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin. (Tripathi A, Davis JD, Staren DM, Volkman BF, Majetschak M) Cytokine 2014 Feb;65(2):121-5 26 Citations |
| 2 | Sulfotyrosine recognition as marker for druggable sites in the extracellular space. (Ziarek JJ, Heroux MS, Veldkamp CT, Peterson FC, Volkman BF) Int J Mol Sci 2011;12(6):3740-56 13 Citations |
